Sysmex Launches an Assay Kit for Identifying p-Tau217 in the Blood, a Biomarker Related to Alzheimer’s Disease

Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui) announced that it has…

Rehabilitation must be at the heart of dementia care across Middle East and Africa, urges new World Alzheimer Report

Dementia cases are rising faster across the Middle East and Africa than…

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that…

FDA Approves Updated Label for GE Healthcare’s Vizamyl to Enhance Alzheimer’s Diagnosis and Therapy Monitoring

GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has…